Moreover, we identified three biomarker genes (CDCA8, MCM6, and NCAPG2) in patients with the highest genomic instability and poor prognosis grouped into a cuproptosis cluster that could be used to design treatment strategies for patients with HCC. This evidence concerns the gene NCAPG2 and hepatocellular carcinoma.